Publication | Closed Access

Effect of recombinant human erythropoietin on lymphocyte phenotyping and phagocyte activity in hemodialysis patients

HemodialysisHemodialysis PatientsPhagocyte ActivityBlood TransfusionChronic Kidney DiseaseHematologyImmunologyBlood CellRecombinant Human ErythropoietinDialysis TherapyMedicineNephrologyAplastic Anemia